12/23
08:12 am
atai
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) [Yahoo! Finance]
Low
Report
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI) [Yahoo! Finance]
12/23
07:00 am
atai
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
Low
Report
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
12/19
01:13 pm
atai
Atai Life Sciences N.V. (ATAI) Secures Patent for Social Anxiety Disorder Formulation [Yahoo! Finance]
Low
Report
Atai Life Sciences N.V. (ATAI) Secures Patent for Social Anxiety Disorder Formulation [Yahoo! Finance]
12/11
07:00 am
atai
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
Low
Report
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
11/25
08:53 am
atai
H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion [Yahoo! Finance]
Low
Report
H.C. Wainwright Maintains Buy on Atai Beckley (ATAI) Following Breakthrough Therapy and Merger Completion [Yahoo! Finance]
11/19
07:32 pm
atai
Enhanced Fortifies Executive Leadership Team & Board of Directors
Medium
Report
Enhanced Fortifies Executive Leadership Team & Board of Directors
11/18
06:38 am
atai
Atai Beckley N.V. (ATAI) Receives Buy Rating on BPL-003 Edge against Spravato [Yahoo! Finance]
Neutral
Report
Atai Beckley N.V. (ATAI) Receives Buy Rating on BPL-003 Edge against Spravato [Yahoo! Finance]
11/13
09:00 am
atai
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
Medium
Report
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
11/12
07:34 am
atai
ATAI Life Sciences GAAP EPS of -$0.28 misses by $0.17, revenue of $0.75M beats by $0.69M [Seeking Alpha]
Medium
Report
ATAI Life Sciences GAAP EPS of -$0.28 misses by $0.17, revenue of $0.75M beats by $0.69M [Seeking Alpha]
11/12
07:00 am
atai
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Low
Report
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
11/11
09:24 am
atai
Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression Transcript [Seeking Alpha]
Low
Report
Atai Beckley N.V. (ATAI) Discusses BPL-003 Phase IIb Open-Label Extension Study Results in Treatment Resistant Depression Transcript [Seeking Alpha]
11/10
07:00 am
atai
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
Medium
Report
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
11/5
07:00 am
atai
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
High
Report
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
10/20
05:29 pm
atai
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
Medium
Report
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
10/18
11:43 am
atai
Atai Life Sciences (ATAI): Evaluating Valuation After FDA Breakthrough Therapy Designation for BPL-003 [Yahoo! Finance]
Medium
Report
Atai Life Sciences (ATAI): Evaluating Valuation After FDA Breakthrough Therapy Designation for BPL-003 [Yahoo! Finance]
10/16
10:31 pm
atai
atai Life Sciences Announces Pricing of Public Offering of Common Shares
High
Report
atai Life Sciences Announces Pricing of Public Offering of Common Shares
10/16
04:12 pm
atai
atai Life Sciences Announces Proposed Public Offering of Common Shares
Medium
Report
atai Life Sciences Announces Proposed Public Offering of Common Shares
10/16
04:10 pm
atai
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
High
Report
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
10/2
12:31 pm
atai
Why Atai Life Sciences (ATAI) Is in Focus After Positive Depression Data and $239M Shelf Registration Filing [Yahoo! Finance]
Low
Report
Why Atai Life Sciences (ATAI) Is in Focus After Positive Depression Data and $239M Shelf Registration Filing [Yahoo! Finance]
9/29
05:42 pm
atai
Atai Life Sciences files to sell 45.32M common shares by selling shareholders [Seeking Alpha]
Low
Report
Atai Life Sciences files to sell 45.32M common shares by selling shareholders [Seeking Alpha]